Choong, Nicholas W <br/><br/>
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Sep 2008 
 - 1003-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e31818396a4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Docetaxel<br/>ErbB Receptors--genetics<br/>Erlotinib Hydrochloride<br/>Etoposide--administration & dosage<br/>Female<br/>Gene Amplification<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use<br/>Remission Induction<br/>Survival Rate<br/>Taxoids--administration & dosage